Skip to main content
OpenTrials
Completed

NCT Number: NCT07398521

A Clinical Trial to Evaluate the Effects of a Supplement on Energy and Mood

This study evaluates the effects of a Liposomal Magnesium Complex supplement on energy and mood. The study is a single-arm, virtual trial in which 60 adult participants consume the supplement daily for 14 days and complete self-reported questionnaires at multiple timepoints.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Citruslabs

Las Vegas, Nevada, 89118, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be male or female
  • Be aged 18-60
  • Anyone currently experiencing issues regarding all of the following: Low energy, Difficulty regulating mood
  • Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
  • Anyone willing to avoid all other dietary supplements or products containing magnesium for the duration of the trial.
  • Anyone willing to refrain from taking any products, prescription medications, or supplements that target energy, mood, stress, and sleep during the test period.
  • Anyone willing to maintain their current diet, sleep schedule, and activity level for the duration of the study.
  • Resides in the United States.

Exclusion criteria

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including cancer and mental health disorders.
  • Anyone with a nut allergy or allergies or sensitivities to any of the product ingredients.
  • Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period).
  • Anyone who drinks heavily (i.e., 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men).
  • History of diagnosed psychiatric or mood disorders.
  • History of diagnosed sleep disorders.
  • History of serious illness in the last three months.
  • History of substance abuse.
  • History of kidney disease.
  • History of hormone or endocrine disorders, including but not limited to hypothyroidism, Hashimoto's thyroiditis, polycystic ovarian syndrome (PCOS), and diabetes.
  • Planned surgery during the study period.
  • Currently partaking in another research study or will be partaking in any other research study for the next 2 weeks, or at any point during this study's duration.
  • Anyone unwilling to follow the study protocol.

Treatment and study plan

Liposomal Magnesium Complex

Dietary Supplement

The supplement is taken in the morning with the first meal of the day for 14 consecutive days.

Primary outcomes

  1. Change in Energy Levels

    Time frame: Baseline, Day 3, Day 7, Day 10, Day 14

    Change in self-reported energy levels following daily use of the Liposomal Magnesium Complex supplement, assessed using participant questionnaires.

  2. Change in Mood

    Time frame: Baseline, Day 3, Day 7, Day 10, Day 14

    Change in self-reported mood following daily use of the Liposomal Magnesium Complex supplement, assessed using participant questionnaires.

Secondary outcomes

  1. Change in Stress Levels

    Time frame: Baseline, Day 3, Day 7, Day 10, Day 14

    Participant-reported changes in perceived stress levels assessed via questionnaire.

  2. Change in Relaxation and Calmness

    Time frame: Baseline, Day 3, Day 7, Day 10, Day 14

    Participant-reported changes in feelings of relaxation and calmness assessed via questionnaire.

  3. Change in Balanced Mood

    Time frame: Baseline, Day 3, Day 7, Day 10, Day 14

    Participant perception of mood balance assessed using self-reported questionnaires.

  4. Change in Sleep Quality

    Time frame: Baseline, Day 3, Day 7, Day 10, Day 14

    Participant-reported changes in sleep assessed via questionnaire.

  5. Change in Muscle Tension

    Time frame: Baseline, Day 3, Day 7, Day 10, Day 14

    Participant-reported changes in muscle tension assessed using questionnaires.

Sponsors and collaborators

Lead sponsor

Cymbiotika, LLC

Industry

Collaborators

  • Citruslabs

Registry information

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Feb 10, 2026
Registry last updated
Feb 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.